| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910140593403321 |
|
|
Autore |
Akasaka Takeshi |
|
|
Titolo |
Chemistry of nanocarbons [[electronic resource] /] / Edited by Takeshi Akasaka, Fred Wudl, Shigeru Nagase |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Chichester, West Sussex, : Wiley, 2010 |
|
|
|
|
|
|
|
ISBN |
|
0-470-97577-6 |
1-283-13875-1 |
9786613138750 |
0-470-66018-X |
0-470-66019-8 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (538 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Nanotubes |
Fullerenes |
Nanodiamonds |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Chemistry of Nanocarbons; Contents; Preface; Acknowledgements; Contributors; Abbreviations; 1 Noncovalent Functionalization of Carbon Nanotubes; 2 Supramolecular Assembly of Fullerenes and Carbon Nanotubes Hybrids; 3 Properties of Fullerene-Containing Dendrimers; 4 Novel Electron Donor Acceptor Nanocomposites; 5 Higher Fullerenes: Chirality and Covalent Adducts; 6 Application of Fullerenes to Nanodevices; 7 Supramolecular Chemistry of Fullerenes: Host Molecules for Fullerenes on the Basis of p-p Interaction; 8 Molecular Surgery toward Organic Synthesis of Endohedral Fullerenes |
9 New Endohedral Metallofullerenes: Trimetallic Nitride Endohedral Fullerenes10 Recent Progress in Chemistry of Endohedral Metallofullerenes; 11 Gadonanostructures as Magnetic Resonance Imaging Contrast Agents; 12 Chemistry of Soluble Carbon Nanotubes: Fundamentals and Applications; 13 Functionalization of Carbon Nanotubes for Nanoelectronic and Photovoltaic Applications; 14 Dispersion and Separation of Single-walled Carbon Nanotubes; 15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Molecular Encapsulations into Interior Spaces of Carbon Nanotubes and Nanohorns; 16 Carbon Nanotube for Imaging of Single Molecules in Motion |
17 Chemistry of Single-Nano Diamond Particles18 Properties of p-electrons in Graphene Nanoribbons and Nanographenes; 19 Carbon Nano Onions; Index; Colour Plates |
|
|
|
|
|
|
Sommario/riassunto |
|
During the last decade, fullerenes and carbon nanotubes have attracted special interest as new nanocarbons with novel properties. Because of their hollow caged structure, they can be used as containers for atoms and molecules, and nanotubes can be used as miniature test-tubes. Chemistry of Nanocarbons presents the most up-to-date research on chemical aspects of nanometer-sized forms of carbon, with emphasis on fullerenes, nanotubes and nanohorns. All modern chemical aspects are mentioned, including noncovalent interactions, supramolecular assembly, dendrimers, nanocomposites, chiralit |
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910778529303321 |
|
|
Autore |
Halpern Sydney A (Sydney Ann) |
|
|
Titolo |
Lesser harms [[electronic resource] ] : the morality of risk in medical research / / Sydney A. Halpern |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Chicago, : University of Chicago Press, 2004 |
|
|
|
|
|
|
|
ISBN |
|
1-282-42657-5 |
9786612426575 |
0-226-31453-7 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (246 p.) |
|
|
|
|
|
|
Collana |
|
Morality and society series |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Human experimentation in medicine - Moral and ethical aspects - United States |
Medicine - Research - Moral and ethical aspects - United States |
Medicine - Research - Law and legislation - United States |
Poliomyelitis vaccine - Research - Moral and ethical aspects - United States |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references (p. 209-222) and index. |
|
|
|
|
|
|
|
|
|
|
|
Nota di contenuto |
|
Front matter -- Contents -- Acknowledgments -- Abbreviations -- Introduction -- 1. The Origins of a Moral Logic of Risk -- 2. Negotiating Moral Boundaries: The Polio Vaccines of 1934-1935 -- 3. Research Sponsors and the Culture of Risk -- 4. Formalizing Responses to Research Hazards -- 5. The Social Nature of Moral Action -- 6. Moral Traditions in an Era of Government Oversight -- Notes -- Selected Bibliography -- Index |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Research physicians face intractable dilemmas when they consider introducing new medical procedures. Innovations carry the promise of preventing or curing life-threatening diseases, but they can also lead to injury or even death. How have clinical scientists made high-stakes decisions about undertaking human tests of new medical treatments? In Lesser Harms, Sydney Halpern explores this issue as she examines vaccine trials in America during the early and mid-twentieth century. Today's scientists follow federal guidelines for research on human subjects developed during the 1960's and 1970's. But long before these government regulations, medical investigators observed informal rules when conducting human research. They insisted that the dangers of natural disease should outweigh the risks of a medical intervention, and they struggled to accurately assess the relative hazards. Halpern explores this logic of risk in immunization controversies extending as far back as the eighteenth century. Then, focusing on the period between 1930 and 1960, she shows how research physicians and their sponsors debated the moral quandaries involved in moving vaccine use from the laboratory to the clinic. This probing work vividly describes the efforts of clinical investigators to balance the benefits and dangers of untested vaccines, to respond to popular sentiment about medical hazards, and to strategically present risk laden research to sponsors and the public. "Concise and extremely well-written. . . . A fascinating synthesis of sociology, history, and institutional theory."-Samuel C. Blackman, Journal of the American Medical Association |
|
|
|
|
|
|
|
| |